Sackler family’s Purdue Pharma wins opioid settlement approval, ending years of lawsuits over OxyContin’s role in addiction crisis.
Purdue Pharma has reached a plan to dissolve the company and replace it with Knoa Pharma as a broad settlement resolving thousands of opioid lawsuits takes effect. The Sackler family’s contributions total up to $7 billion over 15 years, with most funds going to government entities to fight the opioid crisis. Individual victims will receive a smaller portion, while many observers urge greater accountability.